Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Pharmacy / 藥學專業學院
  4. Clinical Pharmacy / 臨床藥學研究所
  5. The Comparison of Serum Teicoplanin Trough Concentrations Under Two Different Loading Doses
 
  • Details

The Comparison of Serum Teicoplanin Trough Concentrations Under Two Different Loading Doses

Date Issued
2007
Date
2007
Author(s)
Liao, Hsin-i
DOI
zh-TW
URI
http://ntur.lib.ntu.edu.tw//handle/246246/55416
Abstract
Background: As one of the first-line therapy for multiresistant Gram-positive infections, teicoplanin exhibits time-dependant killing. Due to the reduced susceptibility to teicoplanin within the past decade, the minimum inhibitory concentrations of clinical methicillin-resistant Staphylococcus aureus isolates increased to 2 mg/L in these years. It is the gold standard to maintain a trough concentration at least 10 mg/L, even 20 mg/L. However, it is known that teicoplanin is high protein binding. Current standard dose, 3-6 mg/Kg, often produces a serum trough level of < 10 mg/L. There is also no commercially avalible drug monitoring method in Taiwan. Because delay in effective therapy is detrimental to clinical outcomes, this study was designed to identify appropriate loading dose to obtain therapeutic concentrations as soon as possible.

Methods: A prospective, single-blinded clinical trial was carried out in a medical center. The sample size was determined by a preliminary observation performed during Febunary 2004 to January 2005. The drug concentrations of these 10 patients were analyzed by high performance liquid chromatography. Patients with suspected moderate gram-positive infections were enrolled during June 2005 to January 2006. A loading dose of 6 or 12 mg/Kg was given every 12 hours for three times and then 24 hours after the third dose. From day 4, patients received a maintenance dose of 6 mg/Kg. The dosing interval was 1 to 3 days according to their creatinine clearance (CLCr). Serum samples before dose 3, 4, 5 and day 9 and 14 were collected to determine the trough concentrations of teicoplanin by fluorescence polarization immunoassay.

Results: Twelve patients were allocated to each group as randomly as possible. The proportions of patints achieving 10 mg/L or higher during the first five doses differed significantly between two groups (18% vs. 92% before the third dose; 17% vs. 91% before the fourth dose; 33% vs. 82% before the fifth dose). Hemodialysis patients or those with CLCr < 20 mL/min/1.73m2 even achieved > 20 mg/L in the higher loading dose group. Obviously, loading dose was the crucial factor for the serum teicoplanin concentrations. Creatinine clearance (β=-0.11, p=0.0043) and the ratio of actual body weight and ideal body weight (β=21.61, p=0.0008) also influenced the trough levels on the third day, indicating actual body weight might not be the approapriate dosing weight.
Besides, looking into the pattern of the changes in the trough concentrations further, higher maintenance dose might be necessary. Patients receiving loading dose of 6 mg/Kg had consitantly low trough concentrations, which half was not higher than 8.5 mg/L. Those in the other group declined over time. A total of 3 patients had trough concentrations below 10 mg/L in two weeks. Dosing interval was determined by creatinine clearance. The cutpoint was 60 and 40 mL/min/1.73m2. Hemodialysis patients kept target concentrations when they received 6 mg/Kg every three days. But 6 mg/Kg every other day might be too small to keep the target trough concentrations during continuous hemofiltration. A total of 8 adverse effects occurred on 7 study subjects (29%). There were no relationship between serum trough concentrations and the occurance of side effects.

Conclusion: Loading doses of 12 mg/Kg would achieve the serum trough concentrations higher than 10 mg/L, even higher than 20 mg/L on patients with CLCr < 20 mL/min/1.73m2 or during hemodialysis in the early treatment period. Higher maintenance dose might be necessary. It was acceptable to adjust the dosing interval of maintainence dose to two and three days for patients with CLCr 40-60 and <40 mL/min/1.73m2, respectively. As for hemodialysis patients, 6 mg/Kg every 3 days was enough. But 6 mg/Kg every other day was not enough to keep target concentrations during continuous hemofiltration. In view of large variation of serum teicoplanin concentrations in different patients, therapeutic drug monitoring was recommended.
Subjects
teicoplanin
藥品動態學
劑量
腎絲球過濾率
藥品療效監測
pharmacokietics
dosage
glomerular filtration rate
therapeutic drug monitoring
Type
text
File(s)
Loading...
Thumbnail Image
Name

ntu-96-R93451002-1.pdf

Size

23.31 KB

Format

Adobe PDF

Checksum

(MD5):6e0abb090a3497a244ed8be60ee1861b

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science